Alberta Investment Management Corp (AIMCo)’s Sarepta Therapeutics SRPT Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,500	Closed	-$2.45M	–	804
2024 Q2	$2.45M	Buy	+15,500	New	+$1.99M	0.03%	316
2020 Q3	–	Sell	-80,272	Closed	-$12.9M	–	1124
2020 Q2	$12.9M	Buy	80,272 +12,963	+19%	+$1.76M	0.15%	160
2020 Q1	$6.58M	Buy	67,309 +12,235	+22%	+$1.4M	0.12%	215
2019 Q4	$7.11M	Hold	55,074	–	–	0.06%	289
2019 Q3	$4.15M	Buy	55,074 +18,557	+51%	+$2.19M	0.04%	372
2019 Q2	$5.55M	Hold	36,517	–	–	0.05%	320
2019 Q1	$4.35M	Buy	36,517 +6,160	+20%	+$792K	0.04%	348
2018 Q4	$3.31M	Buy	30,357 +7,357	+32%	+$920K	0.04%	349
2018 Q3	$3.71M	Buy	+23,000	New	+$3.14M	0.03%	391

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s SRPT Position: Q3 2024 in Review

Alberta Investment Management Corp (AIMCo) sold out of Sarepta Therapeutics (SRPT) in Q3 2024, closing a stake of 15,500 shares — an estimated $2.45M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in SRPT in Q3 2018 and held it in 9 quarters. The position peaked at $12.9M in Q2 2020. 457 funds tracked by Wall St. Rank hold SRPT as of Q3 2024.

Alberta Investment Management Corp (AIMCo) reported no remaining Sarepta Therapeutics position as of Q3 2024 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 15,500 Sarepta Therapeutics shares in Q3 2024, an estimated $2.45M.
Alberta Investment Management Corp (AIMCo) first reported a position in Sarepta Therapeutics in Q3 2018 and held it in 9 quarters.
Alberta Investment Management Corp (AIMCo)'s Sarepta Therapeutics position peaked at $12.9M in Q2 2020.
457 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2024.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2024, filed 5 Nov 2024.